603538 美诺华
已收盘 10-30 15:00:00
资讯
新帖
简况
美诺华（603538）2026年三季报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 10-31 11:26
美诺华（603538）2026年三季报简析：营收净利润同比双双增长，应收账款上升
美诺华(603538)9月30日股东户数8.58万户，较上期增加94.7%
证券之星 · 10-30 19:07
美诺华(603538)9月30日股东户数8.58万户，较上期增加94.7%
图解美诺华三季报：第三季度单季净利润同比下降13.74%
证券之星 · 10-30 01:01
图解美诺华三季报：第三季度单季净利润同比下降13.74%
美诺华（603538）披露2026年第三季度报告，10月29日股价下跌2.73%
证券之星 · 10-29 22:05
美诺华（603538）披露2026年第三季度报告，10月29日股价下跌2.73%
美诺华：原料药、中间体业务产能利用率持续处于较高水平
证券之星 · 10-23
美诺华：原料药、中间体业务产能利用率持续处于较高水平
美诺华：JH389已成为公司独有的特色创新管线产品
证券之星 · 10-23
美诺华：JH389已成为公司独有的特色创新管线产品
美诺华：截至2026年6月30日，公司普通股股东总数为44,076户
证券之星 · 10-23
美诺华：截至2026年6月30日，公司普通股股东总数为44,076户
美诺华（603538）10月22日主力资金净卖出3825.74万元
证券之星 · 10-23
美诺华（603538）10月22日主力资金净卖出3825.74万元
10月22日美诺华跌6.07%，富国致航量化选股股票A基金重仓该股
证券之星 · 10-22
10月22日美诺华跌6.07%，富国致航量化选股股票A基金重仓该股
美诺华（603538）披露变更保荐机构后签订四方监管协议公告，10月21日股价上涨1.76%
证券之星 · 10-21
美诺华（603538）披露变更保荐机构后签订四方监管协议公告，10月21日股价上涨1.76%
美诺华（603538）披露向特定对象发行股票募集说明书（申报稿），10月19日股价下跌9.06%
证券之星 · 10-19
美诺华（603538）披露向特定对象发行股票募集说明书（申报稿），10月19日股价下跌9.06%
10月19日美诺华跌9.06%，富国致航量化选股股票A基金重仓该股
证券之星 · 10-19
10月19日美诺华跌9.06%，富国致航量化选股股票A基金重仓该股
美诺华（603538）10月14日主力资金净卖出8349.18万元
证券之星 · 10-15
美诺华（603538）10月14日主力资金净卖出8349.18万元
美诺华（603538）10月13日主力资金净卖出4494.09万元
证券之星 · 10-14
美诺华（603538）10月13日主力资金净卖出4494.09万元
10月12日美诺华跌7.28%，富国致航量化选股股票A基金重仓该股
证券之星 · 10-12
10月12日美诺华跌7.28%，富国致航量化选股股票A基金重仓该股
美诺华（603538）10月9日主力资金净买入124.15万元
证券之星 · 10-10
美诺华（603538）10月9日主力资金净买入124.15万元
9月30日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股
证券之星 · 09-30
9月30日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股
异动快报：美诺华（603538）9月30日9点48分触及涨停板
证券之星 · 09-30
异动快报：美诺华（603538）9月30日9点48分触及涨停板
美诺华（603538）披露关于变更保荐机构及保荐代表人的公告，9月29日股价下跌0.54%
证券之星 · 09-29
美诺华（603538）披露关于变更保荐机构及保荐代表人的公告，9月29日股价下跌0.54%
美诺华（603538）9月24日主力资金净卖出1.01亿元
证券之星 · 09-25
美诺华（603538）9月24日主力资金净卖出1.01亿元
加载更多
公司概况
公司名称：
宁波美诺华药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-07
主营业务：
宁波美诺华药业股份有限公司的主营业务是特色原料药和制剂研发、生产与销售。公司的主要产品是医药中间体、原料药、制剂。公司是中国化学制药百强企业、宁波市制造业百强企业、宁波竞争力百强企业、浙江省成长最快百强企业。
发行价格：
14.03
{"stockData":{"symbol":"603538","market":"SH","secType":"STK","nameCN":"美诺华","latestPrice":20.9,"timestamp":1793343600000,"preClose":20.28,"halted":0,"volume":36751903,"delay":0,"changeRate":0.0306,"floatShares":337000000,"shares":340000000,"eps":0.3249,"marketStatus":"已收盘","change":0.62,"latestTime":"10-30 15:00:00","open":20.55,"high":21.99,"low":19.6,"amount":762000000,"amplitude":0.1179,"askPrice":20.9,"askSize":959,"bidPrice":20.89,"bidSize":195,"shortable":0,"etf":0,"ttmEps":0.3249,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":20.28,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":22.31,"lowLimit":18.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":339928188,"isCdr":false,"pbRate":2.42,"roa":"--","peRate":64.327485,"roe":"3.95%","epsLYR":0.48,"committee":-0.622329,"marketValue":7104000000,"turnoverRate":0.1091,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-02。","floatMarketCap":7042000000},"requestUrl":"/m/hq/s/603538","defaultTab":"news","newsList":[{"id":"2679222470","title":"美诺华（603538）2026年三季报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222470?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:26","pubTimestamp":1793417212,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期美诺华发布2026年三季报。截至本报告期末，公司营业总收入14.41亿元，同比上升29.0%，归母净利润1.04亿元，同比上升8.54%。按单季度数据看，第三季度营业总收入5.82亿元，同比上升32.41%，第三季度归母净利润4043.2万元，同比下降13.74%。本报告期美诺华应收账款上升，应收账款同比增幅达57.2%。本文数据来源于美诺华2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100024186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679218446","title":"美诺华(603538)9月30日股东户数8.58万户，较上期增加94.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679218446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679218446?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:07","pubTimestamp":1793358423,"startTime":"0","endTime":"0","summary":"证券之星消息，近日美诺华披露，截至2026年9月30日公司股东户数为8.58万户，较6月30日增加4.17万户，增幅为94.7%。在化学制药行业个股中，美诺华股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.98万户。从股价来看，2026年6月30日至2026年9月30日，美诺华区间涨幅为23.46%，在此期间股东户数增加4.17万户，增幅为94.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679287999","title":"图解美诺华三季报：第三季度单季净利润同比下降13.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679287999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679287999?lang=zh_cn&edition=full","pubTime":"2026-10-30 01:01","pubTimestamp":1793293312,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华2026年三季报显示，前三季度公司主营收入14.41亿元，同比上升29.0%；归母净利润1.04亿元，同比上升8.54%；扣非净利润9887.05万元，同比上升14.49%；其中2026年第三季度，公司单季度主营收入5.82亿元，同比上升32.41%；单季度归母净利润4043.2万元，同比下降13.74%；单季度扣非净利润3547.16万元，同比下降28.49%；负债率36.61%，投资收益826.79万元，财务费用2974.02万元，毛利率27.32%。财报数据概要请见下图:本文数据来源于美诺华2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000002750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679732285","title":"美诺华（603538）披露2026年第三季度报告，10月29日股价下跌2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679732285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679732285?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:05","pubTimestamp":1793282755,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，美诺华报收于20.28元，较前一交易日下跌2.73%，最新总市值为68.94亿元。该股当日开盘20.8元，最高21.12元，最低20.28元，成交额达3.36亿元，换手率为4.85%。近日，宁波美诺华药业股份有限公司披露《2026年第三季度报告》。公告显示，本报告期营业收入为581,888,766.68元，同比增长32.41%；归属于上市公司股东的净利润为40,432,038.70元，同比下降13.74%。年初至报告期末，营业收入为1,440,705,900.28元，同比增长29.00%；归属于上市公司股东的净利润为104,121,177.79元，同比增长8.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900062701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677194753","title":"美诺华：原料药、中间体业务产能利用率持续处于较高水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2677194753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677194753?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:18","pubTimestamp":1792747105,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华(603538)10月23日在投资者关系平台上答复投资者关心的问题。投资者提问：宣城美诺华完成FDA审计后，是否意味着该基地具备了更多承接默沙东亚太区创新小分子订单的资质？产能利用率目前处于什么水平？美诺华回复：尊敬的投资者您好，感谢您的关注。公司的原料药、中间体业务产能利用率持续处于较高水平，制剂业务产能亦趋于饱和，公司正通过产能扩建配合客户订单增长需求。关于宣城美诺华的其他经营进展，请以公司公告为准。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677947378","title":"美诺华：JH389已成为公司独有的特色创新管线产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2677947378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677947378?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:18","pubTimestamp":1792747089,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华10月23日在投资者关系平台上答复投资者关心的问题。JH389为公司益生菌产品，前期国内人体试食试验已完成。公司已与本项目的技术合作方签署相关协议，购买技术合作方持有的剩余项目所有权益，JH389已成为公司独有的特色创新管线产品。提请关注：JH389目前尚处于注册及商业化早期阶段，存在注册延期、商业化进展不及预期等不确定性，敬请投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677420729","title":"美诺华：截至2026年6月30日，公司普通股股东总数为44,076户","url":"https://stock-news.laohu8.com/highlight/detail?id=2677420729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677420729?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:12","pubTimestamp":1792746739,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华10月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请公布下截止2026-8-30的股东数，别的公司一般都随半年报公布了。公司已按照相关规定在定期报告中披露报告期末股东总数：截至2026年6月30日，公司普通股股东总数为44,076户，详见公司《2026年半年度报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300031221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677918026","title":"美诺华（603538）10月22日主力资金净卖出3825.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677918026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677918026?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:29","pubTimestamp":1792715352,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月22日收盘，美诺华报收于21.21元，下跌6.07%，换手率7.27%，成交量24.49万手，成交额5.32亿元。近5日资金流向一览见下表：美诺华融资融券信息显示，融资方面，当日融资买入2529.96万元，融资偿还4677.35万元，融资净偿还2147.39万元。美诺华主营业务：专业从事特色原料药和制剂研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300007650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677495833","title":"10月22日美诺华跌6.07%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677495833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677495833?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:34","pubTimestamp":1792658094,"startTime":"0","endTime":"0","summary":"根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为21.79%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200028465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677400677","title":"美诺华（603538）披露变更保荐机构后签订四方监管协议公告，10月21日股价上涨1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677400677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677400677?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:12","pubTimestamp":1792591943,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，美诺华报收于22.58元，较前一交易日上涨1.76%，最新总市值为76.76亿元。该股当日开盘22.55元，最高23.24元，最低22.44元，成交额达6.1亿元，换手率为7.94%。近日，宁波美诺华药业股份有限公司发布《关于变更保荐机构后签订四方监管协议的公告》。公告显示，公司因变更保荐机构为国泰海通证券股份有限公司，原保荐机构万联证券尚未完成的2021年公开发行可转换公司债券募集资金持续督导工作由国泰海通承接。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676504867","title":"美诺华（603538）披露向特定对象发行股票募集说明书（申报稿），10月19日股价下跌9.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676504867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676504867?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:22","pubTimestamp":1792401772,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，美诺华报收于21.69元，较前一交易日下跌9.06%，最新总市值为73.73亿元。该股当日开盘23.3元，最高23.36元，最低21.49元，成交额达8.28亿元，换手率为11.15%。近日，宁波美诺华药业股份有限公司披露《向特定对象发行股票证券募集说明书（申报稿）》。本次发行股票数量不超过101,978,456股，不超过发行前总股本的30%。发行底价为定价基准日前20个交易日公司股票交易均价的80%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900022039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676609509","title":"10月19日美诺华跌9.06%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676609509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676609509?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:29","pubTimestamp":1792398566,"startTime":"0","endTime":"0","summary":"根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为21.56%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675754443","title":"美诺华（603538）10月14日主力资金净卖出8349.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675754443","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675754443?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:28","pubTimestamp":1792024123,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，美诺华报收于24.17元，下跌4.99%，换手率9.03%，成交量30.41万手，成交额7.48亿元。近5日资金流向一览见下表：美诺华融资融券信息显示，融资方面，当日融资买入3327.64万元，融资偿还5205.15万元，融资净偿还1877.5万元。美诺华主营业务：专业从事特色原料药和制剂研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500007096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675957873","title":"美诺华（603538）10月13日主力资金净卖出4494.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675957873","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675957873?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:25","pubTimestamp":1791937532,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，美诺华报收于25.44元，下跌3.56%，换手率13.61%，成交量45.84万手，成交额11.51亿元。近5日资金流向一览见下表：美诺华融资融券信息显示，融资方面，当日融资买入5634.51万元，融资偿还7367.72万元，融资净偿还1733.21万元。美诺华主营业务：专业从事特色原料药和制剂研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674878391","title":"10月12日美诺华跌7.28%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674878391","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674878391?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:37","pubTimestamp":1791794271,"startTime":"0","endTime":"0","summary":"证券之星消息，10月12日美诺华跌7.28%，收盘报26.38元，换手率14.01%，成交量47.19万手，成交额12.77亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为29.11%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200021713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674386069","title":"美诺华（603538）10月9日主力资金净买入124.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674386069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674386069?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:26","pubTimestamp":1791592019,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，美诺华报收于28.45元，下跌3.43%，换手率19.33%，成交量65.13万手，成交额18.23亿元。近5日资金流向一览见下表：美诺华融资融券信息显示，融资方面，当日融资买入1.15亿元，融资偿还1.33亿元，融资净偿还1807.24万元。美诺华主营业务：专业从事特色原料药和制剂研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000004070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274158","title":"9月30日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671274158?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:33","pubTimestamp":1790757237,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日美诺华涨10.00%，收盘报28.59元，换手率14.11%，成交量47.55万手，成交额13.24亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。富国致航量化选股股票A目前规模为1.02亿元，最新净值1.4158，较上一交易日上涨0.93%，近一年上涨12.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000025773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671229086","title":"异动快报：美诺华（603538）9月30日9点48分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2671229086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671229086?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:50","pubTimestamp":1790733035,"startTime":"0","endTime":"0","summary":"证券之星9月30日盘中消息，9点48分美诺华（603538）触及涨停板。其所属行业化学制药目前上涨。领涨股为键凯科技。该股为减肥药，医药，合成生物概念热股，当日减肥药概念上涨2.46%，医药概念上涨1.77%，合成生物概念上涨1.77%。9月29日的资金流向数据方面，主力资金净流出2342.86万元，占总成交额2.37%，游资资金净流入2627.24万元，占总成交额2.65%，散户资金净流出284.38万元，占总成交额0.29%。近5日资金流向一览见下表：美诺华主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000009752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671102242","title":"美诺华（603538）披露关于变更保荐机构及保荐代表人的公告，9月29日股价下跌0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671102242","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671102242?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:05","pubTimestamp":1790690722,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，美诺华报收于25.99元，较前一交易日下跌0.54%，最新总市值为88.35亿元。近日，宁波美诺华药业股份有限公司发布《关于变更保荐机构及保荐代表人的公告》。原保荐机构万联证券的持续督导职责终止。公司对万联证券在前次发行及持续督导期间的工作表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900039613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670194224","title":"美诺华（603538）9月24日主力资金净卖出1.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670194224","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670194224?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:33","pubTimestamp":1790296392,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，美诺华报收于26.76元，下跌3.67%，换手率10.35%，成交量34.86万手，成交额9.48亿元。近5日资金流向一览见下表：美诺华融资融券信息显示，融资方面，当日融资买入6797.15万元，融资偿还7012.76万元，融资净偿还215.61万元。美诺华主营业务：专业从事特色原料药和制剂研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005305.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793476102494,"stockEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":-0.269},{"period":"3month","weight":-0.1545},{"period":"6month","weight":-0.5297},{"period":"1year","weight":0.294},{"period":"ytd","weight":0.5268}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波美诺华药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"85814人(较上一季度增加94.70%)","perCapita":"3926股","listingDate":"2017-04-07","address":"浙江省宁波市鄞州区高新区菁华路777号1号楼7楼","registeredCapital":"33992万元","survey":" 宁波美诺华药业股份有限公司的主营业务是特色原料药和制剂研发、生产与销售。公司的主要产品是医药中间体、原料药、制剂。公司是中国化学制药百强企业、宁波市制造业百强企业、宁波竞争力百强企业、浙江省成长最快百强企业。","listedPrice":14.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美诺华,603538,美诺华股票,美诺华股票老虎,美诺华股票老虎国际,美诺华行情,美诺华股票行情,美诺华股价,美诺华股市,美诺华股票价格,美诺华股票交易,美诺华股票购买,美诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}